Country-wise Listing - Canada

To view the articles from different countries, Please click on the country name on left side countries menu.
S.NO Title & Authors Name page
Innovative training program for pharmacists in the Second Xiangya Hospital of Central South University
Hoan Linh Banh, Ping Xu, Da Xiong Xiang, Andrew Cave
 Abstract                  View                 Download                 XML
Pharmacists are one of the most accessible health care providers in many parts of the world, including China. To better prepare pharmacists to provide pharmaceutical care and comprehensive care, often they are sent to train in a developed countries such as Canada. Because the health care systems are completely different between the countries, most of the pharmacists have difficulties applying their newly acquired skills and knowledge to their own health care. As a result, the Second Xiangya Hospital of Central South University agreed to second a Faculty Member/pharmacist for 8 months. The Faculty member will be at the Second Xiangya Hospital of Central South University to implement a pharmacy clinical program and a structured training program for pharmacists.
Hoan Linh Banh, Andrew Cave
 Abstract                  View                 Download                 XML
The use of inhaled corticosteroids (ICS) is the standard maintenance therapy in the management of asthma and moderate to severe chronic obstructive pulmonary disease (COPD). It is well recognized that systemic corticosteroid therapy is a risk factor for osteoporosis. There is a dose related increase in risk of fracture with ICS use and an inverse relationship between bone mineral density and duration and cumulative dose of ICS. The objective of the study is to assess Alberta pharmacists’ awareness of ICS and its association with osteoporosis. An online survey was created through Google Document® . The URL link to the survey along with a letter of information was circulated to various pharmacy websites. Total of 104 pharmacists completed the survey. Only 60% of the pharmacists are aware of the risk of osteoporosis associated with high dose ICS (>2 mg inhaled beclomethasone/day or equivalent). Less than 50% of the pharmacists would recommend calcium and vitamin D to patients who are receiving long-term high dose ICS. Pharmacists are the most accessible health care providers and can play a pivotal role in identifying patients on ICS who are at risk of osteoporosis. More education is needed for pharmacists to raise the awareness of the association of ICS with osteoporosis.